nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of My Precise Dose and WAPPS-Hemo as dosing tools for optimizing prophylaxis in children with hemophilia A treated with BAY 81-8973
|
Zhou, Yaohan |
|
|
249 |
C |
p. |
artikel |
2 |
Analysis of clinical manifestations and molecular pathogenesis of six patients with hereditary blood coagulation factor VII deficiency
|
Song, Yu |
|
|
249 |
C |
p. |
artikel |
3 |
A survey on clinical practice in monitoring and management of bleeding in children with haemophilia A on emicizumab prophylaxis in the PedNet centres
|
Ranta, Susanna |
|
|
249 |
C |
p. |
artikel |
4 |
Clinical outcomes of direct oral anticoagulants in patients with thrombosis in unusual sites: Insights from a tertiary care center
|
Moragón-Ledesma, Sergio |
|
|
249 |
C |
p. |
artikel |
5 |
Comment on: “Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis”
|
Kumar, Shubham |
|
|
249 |
C |
p. |
artikel |
6 |
Development of a clinically relevant rat model of chronic thromboembolic pulmonary hypertension by combining splenectomy with pulmonary thromboembolism
|
Zhang, Haobing |
|
|
249 |
C |
p. |
artikel |
7 |
Editorial Board
|
|
|
|
249 |
C |
p. |
artikel |
8 |
Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis
|
Li, Wenchi |
|
|
249 |
C |
p. |
artikel |
9 |
Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis
|
Squizzato, Alessandro |
|
|
249 |
C |
p. |
artikel |
10 |
FVIII half-life products: A real-world experience
|
Zanon, Ezio |
|
|
249 |
C |
p. |
artikel |
11 |
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study
|
Mayger, Katarzyna |
|
|
249 |
C |
p. |
artikel |
12 |
Loss of von Willebrand factor large multimers in patients undergoing hemodialysis: A single-center, retrospective study
|
Fujii, Yoshinari |
|
|
249 |
C |
p. |
artikel |
13 |
Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2
|
Kuno, Takahiro |
|
|
249 |
C |
p. |
artikel |
14 |
Metabolomics profiling in venous thromboembolism and its chronic sequelae - A systematic review
|
Amirsardari, Zahra |
|
|
249 |
C |
p. |
artikel |
15 |
Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study
|
Haisma, Bauke |
|
|
249 |
C |
p. |
artikel |
16 |
Platelet count trajectory patterns and prognosis in critically ill patients with thrombocytopenia: Based on latent growth mixture model analysis
|
Li, Jiamei |
|
|
249 |
C |
p. |
artikel |
17 |
The efficacy and safety of low-molecular-weight heparins for venous thromboembolism prophylaxis in abdominal or pelvic cancer surgery: A systematic review and network meta-analysis of randomized controlled trials
|
Liu, Kun |
|
|
249 |
C |
p. |
artikel |
18 |
Understanding primary antiphospholipid syndrome: Analyzing antiphospholipid antibody profile and titers correlation to hematological activity and development of predictive models
|
Llorente-Chávez, Amaya |
|
|
249 |
C |
p. |
artikel |
19 |
Who are we bridging? Description of warfarin patients receiving injectable bridging therapy
|
Vazquez, Sara R. |
|
|
249 |
C |
p. |
artikel |